Selling, importing, or manufacturing pharmaceuticals, medical devices, cosmetics, or health food supplements in Mainland China requires mandatory clearance from the National Medical Products Administration (NMPA) (formerly CFDA). The NMPA enforces strict quality, safety, and testing regulations to protect consumer health. As a leading China regulatory compliance and market-entry advisory firm, we assist global companies in securing these registrations, ensuring full compliance with national standards, and structuring local representation. Failing to obtain NMPA registration results in customs (GACC) seizures, immediate retail platform ban, and heavy administrative penalties.
Role of the NMPA in China Market Access
The NMPA is the administrative organ responsible for regulating drugs, medical devices, cosmetics, and food supplements in Mainland China. To control safety and efficacy, the NMPA works through sub-agencies like the Center for Drug Evaluation (CDE) and the Center for Medical Device Evaluation (CMDE), which perform comprehensive technical audits of dossiers. All filings and technical reviews are processed through centralized electronic systems, requiring precise raw data, QMS records, and product formulation profiles.
The Mandatory Local Representation System
To register imported products, foreign companies without a local China branch must designate an in-country legal representative to act as the primary liaison and licensee. The specific terminology depends on the industry sector:
- Domestic Agent / Local Representative (境内代理人): Required for all foreign medical device and pharmaceutical manufacturers. The Domestic Agent handles the registration dossier, coordinate safety monitoring, and assumes joint liability for quality and post-market safety.
- Domestic Responsible Person (DRP / 境内责任人): Required for foreign cosmetics filers and registrants under the Cosmetic Supervision and Administration Regulation (CSAR). The DRP manages notifications, handles import customs registration, coordinates with testing centers, and bears local liability for product safety.
- Legal Agent (境内主要负责人): Designated for foreign drug marketing authorization holders (MAH) executing applications through the CDE.
Key Benefits of Compliant NMPA Registrations
Securing a valid NMPA registration is a major commercial asset that establishes market presence and protects your investments in China:
- Unlocking the China Market Fulfilling NMPA mandates allows legal import clearance at GACC customs checkpoints and permits nationwide distribution in Chinese hospitals and pharmacies.
- Protection of Formula Secrets Designating an independent Domestic Agent/DRP to hold your registrations protects your sensitive formula details and manufacturing processes from being shared with local sales distributors.
- Public Procurement Eligibility Valid medical device and drug registrations allow foreign brands to bid on China's massive state-run centralized hospital purchase programs (集中采购).
- Retail Platform Access Major domestic e-commerce systems require NMPA filing codes or registration certificates before allowing cosmetics or supplements to open flagship stores.
NMPA Compliance Pathways by Sector
The registration process and data requirements vary dynamically depending on the product type and risk classification:
1. Medical Devices & In-Vitro Diagnostics (IVDs)
Medical devices are categorized into three risk-based classes, which dictate the technical evaluation pathway overseen by the CMDE:
- Class I (Low Risk): E.g., basic surgical tools, bandages, manual hospital beds. Requires a simple administrative filing (备案) with NMPA. No local laboratory testing or clinical trials are needed.
- Class II (Medium Risk): E.g., blood pressure monitors, catheters, ultrasound scanners. Requires local sample testing in NMPA-certified laboratories, a complete technical dossier, a clinical evaluation report (CER), and formal registration (注册).
- Class III (High Risk): E.g., cardiac pacemakers, implants, artificial joints. Subject to strict registry lab tests, clinical evaluation or local clinical trials in China, and formal registration approval.
2. Cosmetics
Under the Cosmetic Supervision and Administration Regulation (CSAR), cosmetics are split into two categories managed via the DRP:
- General/Ordinary Cosmetics: E.g., basic skincare, makeup, shampoo. Managed via a simplified online filing (备案) portal. Exemption from animal testing is possible if the manufacturer holds a government-issued QMS certificate and submits a complete safety assessment report.
- Special Cosmetics: E.g., hair dyes, sunscreens, whitening products, anti-hair loss items. Subject to mandatory registry lab testing, animal testing requirements, and formal registration approval (注册) by the NMPA.
3. Pharmaceuticals
Managed under the Center for Drug Evaluation (CDE). Drugs are classified into chemical drugs, biological products, and traditional Chinese medicine (TCM). Foreign applicants must appoint a Legal Agent, submit global manufacturing dossiers, undergo QMS audits, and conduct localized clinical trials in Mainland China before receiving drug marketing authorization.
4. Health Foods & Dietary Supplements
Supplements are managed under a two-track system: Filing (备案) is available for standard products (like vitamins and minerals) using raw materials listed in the Health Food Raw Material Directory. Registration (注册) is mandatory for supplements introducing new active ingredients or making specific functional health claims (e.g., anti-fatigue).
Our Regulatory Affairs & Registration Services
We provide comprehensive advisory services to guide foreign manufacturers through every phase of NMPA compliance:
- Domestic Agent & DRP Representation: Serving as your independent local representative, holding your licenses, and managing ongoing compliance.
- Product Classification & Feasibility: Analyzing product ingredients, parameters, and indicators against active Chinese regulatory directories.
- Local Laboratory Testing Management: Coordinating sample shipments, lab booking, and testing protocols in certified Chinese laboratories.
- Dossier Compilation & e-RPS Support: Assembling, translating, and formatting technical files, manufacturing details, and QMS certificates.
- Simplified Chinese Labeling Audits: Reviewing and adjusting packaging texts, warnings, and manuals to meet national GB labeling standards.
- Post-Market Surveillance & Safety: Managing adverse event (AE) logging, periodic reporting (PSUR), and recall procedures.
The NMPA Product Registration Process
Securing market access through the NMPA is a structured regulatory journey:
Why Select Our Firm for NMPA Compliance?
We combine deep regulatory expertise, localized agent systems, and strong lab networks to support foreign manufacturers:
- Dedicated Scientific Specialists Our teams include chemists, biomedical engineers, and regulatory attorneys who compile and audit dossiers to meet strict standards.
- Independent Local Representation We provide independent Domestic Agent, DRP, and Legal Agent representation, keeping your registration certificates secure from distributors.
- Formulation Pre-Auditing We audit product ingredients against active directories (like the IECIC for cosmetics) to identify banned substances prior to testing.
- Accredited Testing Coordination We manage local sample shipments and lab booking directly, reducing test failure risks and customs clearance delays.
Deliverables You Receive
Frequently Asked Questions
Check Your Product Compliance Today
Avoid border delays. Let our regulatory specialists manage your NMPA submissions, lab testing, and Domestic Agent representation.
Check NMPA Compliance